Lindbrook Capital’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-22
| Closed | -$246 | – | 2736 |
|
|
2023
Q3 | $246 | Sell |
22
-69
| -76% | -$772 | ﹤0.01% | 2620 |
|
|
2023
Q2 | $1.95K | Buy |
91
+80
| +727% | +$1.71K | ﹤0.01% | 2158 |
|
|
2023
Q1 | $445 | Sell |
11
-28
| -72% | -$1.13K | ﹤0.01% | 2626 |
|
|
2022
Q4 | $1.81K | Buy |
39
+26
| +200% | +$1.21K | ﹤0.01% | 2274 |
|
|
2022
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 2305 |
|
|
2022
Q2 | $1K | Sell |
13
-73
| -85% | -$5.62K | ﹤0.01% | 2216 |
|
|
2022
Q1 | $6K | Buy |
86
+73
| +562% | +$5.09K | ﹤0.01% | 1514 |
|
|
2021
Q4 | $1K | Hold |
13
| – | – | ﹤0.01% | 1905 |
|
|
2021
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 1700 |
|
|
2021
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 1744 |
|
|
2021
Q1 | $1K | Hold |
13
| – | – | ﹤0.01% | 1697 |
|
|
2020
Q4 | $1K | Sell |
13
-11
| -46% | -$846 | ﹤0.01% | 1600 |
|
|
2020
Q3 | $1K | Sell |
24
-29
| -55% | -$1.21K | ﹤0.01% | 1537 |
|
|
2020
Q2 | $3K | Buy |
53
+20
| +61% | +$1.13K | ﹤0.01% | 1246 |
|
|
2020
Q1 | $2K | Buy |
+33
| New | +$2K | ﹤0.01% | 1280 |
|